Veterinary medicinal product register

The FVS registers website is using cookies. By continuing using this website you are agreeing to use cookies. Agree Cookies policy
Data selected by 7
Original name Strength Marketing authorisation number Marketing authorisation holder: ATCvet code Species More
V.H. + H-120 - V/NRP/10/0033 PHIBRO ANIMAL HEALTH (POLAND) Sp. z o.o., Polija QI01AD chickens Vairāk

Medicinal product information

Pharmaceutical form: lyophilisate for use in drinking water
International name (active substance): Live Newcastle Disease virus, Infectious Avian bronchitis virus, strain H120
Distribution category: To be used only by veterinary surgeon
Manufacturer(s) responsible for batch release Synoptis Industrial Sp. z o.o., Polija
Date of authorisation/renewal: 27-Oct-2015
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [DOCX] 231123_LI (23-Nov-2023)
Labelling text: [DOCX] 190920M (19-Sep-2020)
Summary of product characteristics: [DOCX] 190920ZA (19-Sep-2020)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/10/0033-01 10 Stikla flakons, 500 deva -
V/NRP/10/0033-02 10 Stikla flakons, 1000 deva -
V/NRP/10/0033-03 10 Stikla flakons, 2000 deva -
V/NRP/10/0033-04 10 Stikla flakons, 2500 deva -
V/NRP/10/0033-05 10 Stikla flakons, 5000 deva -
Marbocyl P 20mg - V/NRP/03/1572 Vetoquinol S.A., Francija QJ01MA93 dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): Marbofloxacin
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Vetoquinol Biowet Sp. z. o. o., Polija;Vetoquinol S.A., Francija
Date of authorisation/renewal: 18-Aug-2008
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] 090710LI (19-Jul-2010)
Labelling text: [DOC] 090710M (19-Jul-2010)
Summary of product characteristics: [PDF] 090710ZA (19-Jul-2010)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/03/1572-01 20 mg 1 Alumīnija blisteris, 10 tablete -
V/NRP/03/1572-02 20 mg 2 Alumīnija blisteris, 10 tablete -
V/NRP/03/1572-03 20 mg 3 Alumīnija blisteris, 10 tablete -
V/NRP/03/1572-04 20 mg 4 Alumīnija blisteris, 10 tablete -
V/NRP/03/1572-05 20 mg 5 Alumīnija blisteris, 10 tablete -
V/NRP/03/1572-06 20 mg 10 Alumīnija blisteris, 10 tablete -
V/NRP/03/1572-07 20 mg 25 Alumīnija blisteris, 10 tablete -
Tetanusan 50% - V/NRP/09/0006 Kon-Pharma GmbH, Vācija QB05XA30 cattle; pigs; horses Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Calcium gluconate, Magnesium chloride hexahydrate, Disodium glycerophosphate
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Kon-Pharma GmbH, Vācija
Date of authorisation/renewal: 08-Apr-2014
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [DOCX] 26012021LI (26-Jan-2021)
Labelling text: [DOCX] 26012021M (26-Jan-2021)
Summary of product characteristics: [DOCX] 26012021ZA (26-Jan-2021)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/09/0006-01 1 Polipropilēna flakons, 500 ml -
Soligental 3000 IU/ml V/NRP/08/1597 Virbac S.A., Francija QS01AA11 dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: eye drops, solution
International name (active substance): Gentamicin sulphate
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Virbac S.A., Francija;Labiana Life Sciences S.A., Spānija
Date of authorisation/renewal: 01-Jul-2013
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (03-Jul-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (03-Jul-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (03-Jul-2024)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/08/1597-01 3000 IU/ml 1 Flakons, 5 ml -
DEPO-MEDRONE V 40 mg/ml V/NRP/02/1505 Zoetis Belgium S.A., Beļģija QH02AB04 horses; dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: suspension for injection
International name (active substance): Methylprednisolone acetate
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Pfizer Manufacturing Belgium , Beļģija
Date of authorisation/renewal: 22-Sep-2008
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (02-Apr-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (02-Apr-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (02-Apr-2024)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/02/1505-01 40 mg/ml 1 Stikla flakons, 5 ml -
Dalmazin 75 µg/ml V/NRP/01/1380 Fatro S.p.A., Itālija QG02AD90 sows; mares; cows Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Cloprostenol sodium
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Fatro S.p.A., Itālija
Date of authorisation/renewal: 04-Jul-2011
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (10-Jun-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (10-Jun-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (10-Jun-2024)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/01/1380-01 75 µg/ml 1 Stikla flakons, 2 ml -
V/NRP/01/1380-02 75 µg/ml 1 Stikla flakons, 10 ml -
V/NRP/01/1380-03 75 µg/ml 1 Stikla flakons, 20 ml -
V/NRP/01/1380-04 75 µg/ml 5 Stikla flakons, 20 ml -
V/NRP/01/1380-05 75 µg/ml 10 Stikla flakons, 10 ml -
V/NRP/01/1380-06 75 µg/ml 15 Stikla flakons, 2 ml -
V/NRP/01/1380-07 75 µg/ml 60 Stikla flakons, 2 ml -
V/NRP/01/1380-08 75 µg/ml 1 Stikla flakons, 50 ml [PDF] [PDF]
V/NRP/01/1380-09 75 µg/ml 1 ABPE flakons, 100 ml -
Sedalin gel 35 mg/ml V/NRP/99/1518 Vetoquinol Biowet Sp. z o.o., Polija QN05AA04 horses; dogs Vairāk

Medicinal product information

Pharmaceutical form: Oral Gel
International name (active substance): Acepromazine (as maleate)
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Vetoquinol Biowet Sp. z o.o., Polija
Date of authorisation/renewal: 30-Mar-2009
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] 210912LI (27-Sep-2012)
Labelling text: [PDF] 210912M (27-Sep-2012)
Summary of product characteristics: [PDF] 210912ZA (27-Sep-2012)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/99/1518-01 35 mg/ml 1 Šļirce, 10 ml -
Cefalexin Virbac - V/NRP/07/1704 Virbac S.A., Francija QJ51DB01 cattle Vairāk

Medicinal product information

Pharmaceutical form: intramammary suspension
International name (active substance): Cefalexin
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Virbac S.A., Francija
Date of authorisation/renewal: 26-Feb-2013
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] 08032022LI (08-Mar-2022)
Labelling text: [PDF] 08032022M (08-Mar-2022)
Summary of product characteristics: [PDF] 08032022ZA (08-Mar-2022)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/07/1704-01 375 mg/deva 12 Injektors, 1 deva -
Nobivac RL - V/NRP/96/0379 Intervet International B.V., Nīderlande QI07AL01 dogs Vairāk

Medicinal product information

Pharmaceutical form: suspension for injection
International name (active substance): Inactivated rabies virus strain Pasteur RIV, Leptospira interrogans, serogroup Canicola, serovar Portland-vere, strain Ca-12-000, Inactivated, Leptospira interrogans, serogroup Icterohaemorrhagiae, serovar Copenhageni, strain 820K, Inactivated
Distribution category: To be used only by veterinary surgeon
Manufacturer(s) responsible for batch release Intervet International Booxmer, Nīderlande
Date of authorisation/renewal: 16-Nov-2010
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [DOCX] 280621LI (28-Jun-2021)
Labelling text: [DOCX] 280621M (28-Jun-2021)
Summary of product characteristics: [DOCX] 280621ZA (28-Jun-2021)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/96/0379-01 10 Stikla flakons (kartona kastē), 1 deva -
V/NRP/96/0379-03 10 Stikla flakons (plastmasas kastē), 1 deva -
Orbenin EDC 600 mg V/NRP/99/0980 Zoetis Belgium S.A., Beļģija QJ51CF02 cows Vairāk

Medicinal product information

Pharmaceutical form: intramammary suspension
International name (active substance): Cloxacillin benzathine
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Haupt Pharma Latina S.R.L., Itālija
Date of authorisation/renewal: 30-Oct-2009
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (16-Sep-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (16-Sep-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (16-Sep-2024)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/99/0980-01 600 mg 24 Injektors, 1 deva -
V/NRP/99/0980-03 600 mg 120 Injektors, 1 deva -
V/NRP/99/0980-04 600 mg 200 Injektors, 1 deva -
V/NRP/99/0980-05 600 mg 1 Injektors, 1 deva -
LV Introvit-B-Complex - V/NRP/12/0042 Interchemie Werken De Adelaar Eesti AS, Igaunija QA11EA cattle; pigs; sheep; goats; horses Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Biotin,Dexpanthenol,Pyridoxine hydrochloride,Riboflavine sodium phosphate,Thiamine hydrochloride,Nicotinamide,Choline chloride,Cyanocobalamin
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Interchemie Werken De Adelaar Eesti AS, Igaunija
Date of authorisation/renewal: 04-Jul-2017
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] 290617LI (04-Jul-2017)
Labelling text: [PDF] 290617M (04-Jul-2017)
Summary of product characteristics: [PDF] 290617ZA (04-Jul-2017)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/12/0042-01 1 Stikla flakons, 100 ml -
LV Biocillin-500 WS 500 mg/ml V/NRP/18/0027 Interchemie Werken De Adelaar Eesti AS, Igaunija QJ01CA04 pigs; chickens Vairāk

Medicinal product information

Pharmaceutical form: powder for use in drinking water
International name (active substance): Amoxicillin trihydrate
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Interchemie Werken De Adelaar Eesti AS, Igaunija
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] 290318LI (05-Apr-2018)
Labelling text: [PDF] 290318M (05-Apr-2018)
Summary of product characteristics: [PDF] 290318ZA (05-Apr-2018)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/18/0027-01 1 Alumīnija folijas maisiņš, 100 g -
V/NRP/18/0027-02 1 ABPE pudele, 1000 g -
LV Biocillin-150 LA 150 mg/ml V/NRP/11/0063 Interchemie Werken De Adelaar Eesti AS, Igaunija QJ01CA04 cattle; pigs; sheep; goats; calves Vairāk

Medicinal product information

Pharmaceutical form: suspension for injection
International name (active substance): Amoxicillin trihydrate
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Interchemie Werken De Adelaar Eesti AS, Igaunija
Date of authorisation/renewal: 30-Nov-2016
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] 281116LI (30-Nov-2016)
Labelling text: [PDF] 281116M (30-Nov-2016)
Summary of product characteristics: [PDF] 281116ZA (30-Nov-2016)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/11/0063-01 150 mg/ml 1 Stikla pudele, 100 ml -
LV Macrolan 200 mg/ml V/NRP/14/0064 Interchemie Werken De Adelaar Eesti AS, Igaunija QJ01FA90 cattle; pigs; sheep; goats Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Tylosin tartrate
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Interchemie Werken De Adelaar Eesti AS, Igaunija
Date of authorisation/renewal: 04-Jun-2019
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] 240120LI (24-Jan-2020)
Labelling text: [PDF] 240120M (24-Jan-2020)
Summary of product characteristics: [PDF] 240120ZA (24-Jan-2020)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/14/0064-01 200 mg/ml 1 Stikla pudele (brūna), 100 ml -
Indigest injectable 100 mg/ml V/NRP/01/1294 Laboratorios Calier, S.A., Spānija QA05AX90 cattle; pigs; sheep; goats; horses; dogs Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Menbutone
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Laboratories Calier S.A., Spānija
Date of authorisation/renewal: 21-May-2008
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (25-Apr-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (25-Apr-2025)
Summary of product characteristics: [DOC] Zāļu_informācija_ZA_M_LI (25-Apr-2025)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/01/1294-02 100 mg/ml 1 Flakons, 100 ml -
Biofel PCHR - V/NRP/17/0006 Bioveta, a.s., Čehija QI06AA09 cats Vairāk

Medicinal product information

Pharmaceutical form: emulsion for injection
International name (active substance): Inactivated feline panleucopenia virus, strain FPV Bio 7,Inactivated feline calicivirus, strain FCV F9 Bio-8,Inactivated feline herpes virus, strain FHV 1 Bio-9,Inactivated rabies virus, strain Vnukovo Bio-16
Distribution category: To be used only by veterinary surgeon
Manufacturer(s) responsible for batch release Bioveta, a.s., Čehija
Date of authorisation/renewal: 20-Dec-2021
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [DOCX] 211221LI (21-Dec-2021)
Labelling text: [DOCX] 211221M (21-Dec-2021)
Summary of product characteristics: [DOC] 211221ZA (21-Dec-2021)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/17/0006-01 2 Stikla flakons, 1 deva -
V/NRP/17/0006-02 10 Stikla flakons, 1 deva -
V/NRP/17/0006-03 5 Stikla flakons, 5 deva -
V/NRP/17/0006-04 10 Stikla flakons, 5 deva -
V/NRP/17/0006-05 20 Stikla flakons, 1 deva -
V/NRP/17/0006-06 100 Stikla flakons, 1 deva -
V/NRP/17/0006-07 1 Stikla flakons, 5 deva -
Phenocoat 5 mg V/DCP/25/0012 Alfasan Nederland BV, Nīderlande QN03AA02 dogs Vairāk

Medicinal product information

Pharmaceutical form: film-coated tablets
International name (active substance): Phenobarbital
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Alfasan Nederland BV, Nīderlande;Lelypharma B.V., Nīderlande
Date of authorisation/renewal: 19-Mar-2025
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (19-Mar-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (19-Mar-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (19-Mar-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/25/0012-01 1 Blisteris, 10 tablete -
V/DCP/25/0012-02 2 Blisteris, 10 tablete -
V/DCP/25/0012-03 3 Blisteris, 10 tablete -
V/DCP/25/0012-04 4 Blisteris, 10 tablete -
V/DCP/25/0012-05 5 Blisteris, 10 tablete -
V/DCP/25/0012-06 6 Blisteris, 10 tablete -
V/DCP/25/0012-07 7 Blisteris, 10 tablete -
V/DCP/25/0012-08 8 Blisteris, 10 tablete -
V/DCP/25/0012-09 9 Blisteris, 10 tablete -
V/DCP/25/0012-10 10 Blisteris, 10 tablete -
V/DCP/25/0012-11 25 Blisteris, 10 tablete -
Phenocoat 12.5 mg V/DCP/25/0013 Alfasan Nederland BV, Nīderlande QN03AA02 dogs Vairāk

Medicinal product information

Pharmaceutical form: film-coated tablets
International name (active substance): Phenobarbital
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Alfasan Nederland BV, Nīderlande;Lelypharma B.V., Nīderlande
Date of authorisation/renewal: 19-Mar-2025
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (19-Mar-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (19-Mar-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (19-Mar-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/25/0013-01 1 Blisteris, 10 tablete -
V/DCP/25/0013-02 2 Blisteris, 10 tablete -
V/DCP/25/0013-03 3 Blisteris, 10 tablete -
V/DCP/25/0013-04 4 Blisteris, 10 tablete -
V/DCP/25/0013-05 5 Blisteris, 10 tablete -
V/DCP/25/0013-06 6 Blisteris, 10 tablete -
V/DCP/25/0013-07 7 Blisteris, 10 tablete -
V/DCP/25/0013-08 8 Blisteris, 10 tablete -
V/DCP/25/0013-09 9 Blisteris, 10 tablete -
V/DCP/25/0013-10 10 Blisteris, 10 tablete -
V/DCP/25/0013-11 25 Blisteris, 10 tablete -
Phenocoat 25 mg V/DCP/25/0014 Alfasan Nederland BV, Nīderlande QN03AA02 dogs Vairāk

Medicinal product information

Pharmaceutical form: film-coated tablets
International name (active substance): Phenobarbital
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Alfasan Nederland BV, Nīderlande;Lelypharma B.V., Nīderlande
Date of authorisation/renewal: 19-Mar-2025
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (19-Mar-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (19-Mar-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (19-Mar-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/25/0014-01 1 Blisteris, 10 tablete -
V/DCP/25/0014-02 2 Blisteris, 10 tablete -
V/DCP/25/0014-03 3 Blisteris, 10 tablete -
V/DCP/25/0014-04 4 Blisteris, 10 tablete -
V/DCP/25/0014-05 5 Blisteris, 10 tablete -
V/DCP/25/0014-06 6 Blisteris, 10 tablete -
V/DCP/25/0014-07 7 Blisteris, 10 tablete -
V/DCP/25/0014-08 8 Blisteris, 10 tablete -
V/DCP/25/0014-09 9 Blisteris, 10 tablete -
V/DCP/25/0014-10 10 Blisteris, 10 tablete -
V/DCP/25/0014-11 25 Blisteris, 10 tablete -
Phenocoat 50 mg V/DCP/25/0015 Alfasan Nederland BV, Nīderlande QN03AA02 dogs Vairāk

Medicinal product information

Pharmaceutical form: film-coated tablets
International name (active substance): Phenobarbital
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Alfasan Nederland BV, Nīderlande;Lelypharma B.V., Nīderlande
Date of authorisation/renewal: 19-Mar-2025
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (19-Mar-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (19-Mar-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (19-Mar-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/25/0015-01 1 Blisteris, 10 tablete -
V/DCP/25/0015-02 2 Blisteris, 10 tablete -
V/DCP/25/0015-03 3 Blisteris, 10 tablete -
V/DCP/25/0015-04 4 Blisteris, 10 tablete -
V/DCP/25/0015-05 5 Blisteris, 10 tablete -
V/DCP/25/0015-06 6 Blisteris, 10 tablete -
V/DCP/25/0015-07 7 Blisteris, 10 tablete -
V/DCP/25/0015-08 8 Blisteris, 10 tablete -
V/DCP/25/0015-09 9 Blisteris, 10 tablete -
V/DCP/25/0015-10 10 Blisteris, 10 tablete -
V/DCP/25/0015-11 25 Blisteris, 10 tablete -

3082 records

© Food and veterinary service · 2026 Cookies policy